Desonate (desonide gel)
/ LEO Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
62
Go to page
1
2
3
September 16, 2026
Topical B5 Repair Cream Combined with Desonide Cream Improves Lichen Simplex Chronicus Lesions via Inhibiting NGF: A Prospective, Self-Bilateral Controlled Trial
(ChiCTR)
- P=N/A | N=40 | Not yet recruiting | Sponsor: The Second Affiliated Hospital of Xi 'an Jiaotong University; The Second Affiliated Hospital of Xi 'an Jiaotong University
New trial • Dermatitis • Dermatology • Immunology
June 09, 2026
Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial.
(PubMed, Front Med (Lausanne))
- "Meanwhile, the foundational therapies include desonide cream for mild AD and triamcinolone acetonide cream for moderate AD, both of which will be applied twice daily for 2 weeks. Findings in this study are expected to provide evidence for the incorporation of traditional Chinese herbal bath solutions into the comprehensive management of AD. https://www.chictr.org.cn/, Identifier ITMCTR2025001206."
Clinical • Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Inflammation • Pruritus
May 13, 2026
Unilateral Onset of Subacute Cutaneous Lupus Erythematosus Mimicking Localized Dermatoses: A Case Report
(EADV-Sp 2026)
- "After treatment with topical desonide 0.05% cream alternating with tacrolimus 0.1% ointment, a tapering course of oral prednisone (20 mg), hydroxychloroquine 200 mg once daily, strict photoprotection, and adjunctive measures, lesions markedly improved with decreased erythema and thickness, resolution on the upper extremities, and a reduced CLASI activity score from 9 to 2 after six weeks, indicating a positive treatment response. This case underscores the importance of including SCLE in the differential diagnosis of persistent, unilateral erythematous papules and plaques of the central face, as early recognition is crucial to prevent disease progression and inappropriate treatment. Timeline of Events"
Case report • Clinical • Cutaneous Lupus Erythematosus • Dermatology • Discoid Lupus Erythematosus • Herpes Zoster • Immunology • Inflammatory Arthritis • Lupus • Rosacea • Varicella Zoster
April 13, 2026
Topical calcineurin inhibitors for atopic dermatitis are not associated with the development of subsequent lymphoma: A pharmacovigilance study using the FAERS database (2014-2025).
(PubMed, JAAD Int)
- No abstract available
Adverse events • Journal • Atopic Dermatitis • Dermatitis • Dermatology • Hematological Malignancies • Immunology • Lymphoma • Oncology
April 23, 2026
Observation of the Efficacy of Rabbit Head Mom Multi-Effect Protective Essence Cream in the Adjuvant Treatment of Mild to Moderate Atopic Dermatitis in Children
(ChiCTR)
- P=N/A | N=100 | Completed | Sponsor: Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai Children's Medical Center, Shanghai Jiao Tong Universit
New trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 04, 2026
Rutin targets PD-L1 for the treatment of atopic dermatitis: network pharmacological analysis and experimental evidence.
(PubMed, Int Immunopharmacol)
- "In summary, this study elucidates a novel mechanism by which rutin ameliorates AD-like inflammation through direct binding and upregulation of PD-L1, leading to enhanced epidermal expression and subsequent immunomodulation. Moreover, compared to conventional medications, rutin effectively reduces TEWL and strengthens the skin barrier. These findings not only advance our understanding of rutin's pharmacological activity but also support the continued investigation of natural compounds as targeted therapeutic agents for inflammatory skin diseases. The convergence of traditional knowledge and modern mechanistic validation presented here underscores the enduring value of the ethnopharmacological approach to in drug discovery."
IO biomarker • Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Infectious Disease • Inflammation • TSLP
February 23, 2026
Drugs for atopic dermatitis.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
February 19, 2026
Investigating the Telomerase Downregulatory Potential of Steroidal Drugs Following Pharmacophore-Based Rational; Computational and In Vitro Assessments.
(PubMed, Arch Pharm (Weinheim))
- "Accordingly, diverse 280 steroidal drugs-following a pharmacophore-based rationale-were docked against telomerase receptor and compared to the co-crystallized inhibitor (BIBR1532) as a reference standard...The antitumor activities of the six steroidal drugs against H1299, HuH7, HCT116, A549, MDA-MB-231, MCF7, PC3, MG63, and A375 cancer cell lines, besides OEC and HSF normal cell lines, were evaluated and compared to doxorubicin (Dox) as a reference positive standard...The outstanding antitumor six steroidal drugs were further investigated for their telomerase downregulatory potentials. All analogs recorded outstanding downregulatory results against telomerase, especially Clobetasone butyrate, Desonide, Diflucortolone valerate, and Hydrocortisone butyrate, where the protein expression for telomerase was downregulated up to 0.66-, 0.76-, 0.56-, and 0.73-fold change for clobetasone butyrate, desonide, diflucortolone valerate, and hydrocortisone butyrate, respectively,..."
Journal • Preclinical • Oncology
January 29, 2026
Hydroxybutyl Chitosan Hydrogel Promotes Ablative Fractional CO2 Laser Wound Healing: A Prospective, Randomized, Split-Face Trial and Animal Model Evidence.
(PubMed, Lasers Surg Med)
- P=N/A | "HBC is effective and safe for promoting wound healing post AFCL. HBC upregulates IRF7 and Ctss expression and promotes macrophage M2 polarization. The expression of IRF7/CTSS may be correlated with M2 polarization of macrophages."
Journal • Preclinical • Acne Vulgaris • Dermatology • Pain • CTSS • EGF • IRF7
October 14, 2025
Letters: The Paradox of Desonide: Treating Inflammation, Triggering Allergy.
(PubMed, Dermatitis)
- No abstract available
Journal • Allergy • Immunology • Inflammation
September 23, 2025
Multifunctional Hydrogel for the Treatment of Atopic Dermatitis: Current Advances and Translational Challenges.
(PubMed, Eur J Pharm Sci)
- "Multiple clinical trials have demonstrated that Desonide hydrogel provides substantial benefits to patients, making the design of multifunctional hydrogel dressings a research hotspot in recent years. This review first summarizes the feasible options for drug loading in hydrogels, then focuses on the advantages and disadvantages of different hydrogel types and drug delivery methods, and finally addresses the challenges and solutions for translating innovative hydrogels into clinical practice. Aimed at integrating perspectives from materials science, dermatology, and translational medicine, this review establishes a theoretical framework for the rational design of innovative hydrogels in local AD therapy."
Journal • Review • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Inflammation • Pruritus
September 10, 2025
Topical Glucocorticoid-Induced Cushing's Syndrome in a Patient with Erythrodermic Psoriasis: A Case Report.
(PubMed, Clin Cosmet Investig Dermatol)
- "Management included gradual withdrawal of topical steroids, initiation of oral methylprednisolone (8 mg daily) for HPA axis support, and transition to low-potency desonide. This case highlights the systemic risks of unsupervised, escalating use of high-potency topical corticosteroids in adults with impaired skin barrier. It underscores the need for adherence to dosing guidelines, patient education, and routine endocrine monitoring."
Journal • Cushing’s Disease • Dermatology • Dermatopathology • Endocrine Disorders • Immunology • Pediatrics • Psoriasis
August 22, 2025
Axillary Hyperpigmentation Treatment: A Systematic Review of the Literature.
(PubMed, J Cosmet Dermatol)
- "The most frequently used laser in treating AH was QS Nd-YAG without having any severe adverse effect. Various topical treatments including Niacinamide, desonide, HQ, AHA, and a few herbal extracts were shown to be effective for AH."
Journal • Review • Pain
April 02, 2025
A Randomized Controlled Study of Oxysophocarpine Cream in the Treatment of Mild to Moderate Atopic Dermatitis
(ChiCTR)
- P=N/A | N=78 | Not yet recruiting | Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Yueyang Hospital of Inte
New trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
February 22, 2025
Not all Herbal Extracts are Equal! Only a few have therapeutic potential
(AAD 2025)
- "Eight of 47 commercially available extracts were found to have significant anti-inflammatory effect superior to or comparable to prescription mometasone, desonide and dexamethasone. Five of these also produced significant inhibition of cutaneous pathogenic bacteria and yeast. Caution is needed in selection of extracts from the species within an herbal family due to large variation of therapeutic activity."
CXCL8 • IL6 • TNFA
February 26, 2025
New Eye Drop Formulation Based on Desonide and Xanthan Gum in Dry Eye Disease: Nonclinical Studies.
(PubMed, Pharmaceutics)
- "This study aimed to evaluate its pharmacodynamic properties and to characterize its rheological behavior and mucoadhesive characteristics, compared to another formulation containing 0.2% hyaluronic acid and 0.001% hydrocortisone (HYD). The ancillary anti-inflammatory effects of a low dose of DES combined with the biophysical properties of xanthan gum are supportive of a favorable therapeutic profile, promoting the maintenance or restoration of ocular surface homeostasis while minimizing the risk of adverse effects typically associated with standard-dose corticosteroids. The comparison with another low-dose corticosteroid highlights the superiority of XanterDES in pharmacodynamic and biophysical performance."
Journal • Corneal Abrasion • Dry Eye Disease • Inflammation • Ocular Inflammation • Ophthalmology • Uveitis
February 03, 2025
A Comparative, Multicenter, Prospective, Randomized Study to Evaluate the Efficacy, Safety, and Delay of Relapse of Ceramide-Based Post-biotic Moisturizer Versus Paraffin-Based Moisturizer in Mild to Moderate Atopic Dermatitis.
(PubMed, Cureus)
- "Although both moisturizers were effective in resolving symptoms in the treatment phase, the ceramide-based post-biotic moisturizer was more effective and statistically significant in extending the remission period against the paraffin-based moisturizer in patients with mild to moderate AD."
Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology • Inflammation
January 22, 2025
Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children.
(PubMed, Medicine (Baltimore))
- "The combination of moisturizing cream and desonide in the treatment of AD in children is highly effective and safe. It is worth promoting for clinical application due to its significant therapeutic effects and high safety profile."
Clinical • Journal • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
September 29, 2024
ALLERGIC CONTACT DERMATITIS TO TOPICAL CORTICOSTEROIDS: WHAT IS THE NEXT STEP IN MANAGEMENT?
(ACAAI 2024)
- "Although initial treatment adhered to established guidelines, including topical triamcinolone acetonide, emollients, and cetirizine, eczema did not improve and worsened. Adjustments to treatment, including introduction of pimecrolimus and topical mupirocin ointment, also failed to produce any improvement...However, the patient showed improvement with the administration of oral prednisolone...Patch tests for triamcinolone acetonide, desonide, and fluocinolone acetonide were positive, showing localized inflammation and worsening of eczema at application sites...Early consideration and use of dupilumab can result in notable clinical benefits for such patients. Consent granted from patient's parents to present case."
Atopic Dermatitis • Contact Dermatitis • Dermatitis • Dermatology • Immunology
August 06, 2024
Different variants of Lichen Planus Pigmentosus in Filipino patients: A case series
(EADV 2024)
- "He began taking Delamanid and Linezolid for multidrug- resistant tuberculosis (MDR-TB) clinical trial in the same month, which then led to extensive hair loss...Patients received treatment with low-dose isotretinoin, topical tacrolimus 0.1%, desonide cream, and photoprotection... The cases show a wide range of etiologies and presentations of lichen planus pigmentosus in Filipino patients. While LPP can occur without a clear cause, potential etiologic agents such as hypopigmenting agents should be considered. Pediatric cases present additional challenges due to rarity and unidentified causes."
Clinical • Alopecia • Dermatitis • Dermatology • Dermatopathology • Human Immunodeficiency Virus • Immunology • Infectious Disease • Lichen Planus • Pediatrics • Pruritus • Respiratory Diseases • Tuberculosis
August 06, 2024
axillary hyperpigmentation treatment: a review of the literature
(EADV 2024)
- "Various topical agents such as hydroquinone (HQ) , tretinoin, and vitamin C as well as light and laser-based treatments namely QS Nd-YAG laser are being used in clinical practice. In this study, we found that both topical in addition to light and laser-based therapies are effective. The studied topical agents for axillary hyperpigmentation were Niacinamide, Desonide, CREO, AHA, HQ, and PFLE. Light and laser therapies applied for axillary hyperpigmentation were QS-Nd YAG and IPL."
Review • Dermatology
August 06, 2024
Decyl-Glucoside; this eco-friendly but skin-unfriendly surfactant:a case report
(EADV 2024)
- "Materials & Case report A 25-year-old female patient with personal and family history of atopy had been presenting with a pruritic facial rash lasting for two months as intermitent episodes, resistant to the usual treatment of her atopic dermatitis (local corticosteroids of moderate class: desonide)... The use of decyl glucoside is becoming increasingly common with the emergence of the “ Green ” label. The cosmetics industry is rediscovering this eco-friendly alkyl glucoside, synthesized from natural, renewable sources and considered a mild surfactant, but it shouldn ’ t escape suspicion during an allergological investigation into contact dermatitis."
Case report • Clinical • Surfactant • Atopic Dermatitis • Contact Dermatitis • Dermatitis • Dermatology • Immunology
August 06, 2024
Oral ketoconazole induced cheilitis: A rare adverse effect
(EADV 2024)
- "It was developed as a first line agent for dermatophytosis, but was soon found to have various side effects, such as hepatotoxicity, leading to it being replaced by safer and effective drugs like terbinafine and itraconazole... Oral ketoconazole was stopped and treatment in the form of desonide 0.05% and petroleum jelly was given to be applied...Her dermatophytosis condition was managed with oral terbinafine and topical ciclopirox cream with significant improvement... Oral ketoconazole can be added to the list of causes of drug-induced cheilitis is, a hitherto unreported cause. Oral ketoconazole, though has varied other side-effects, such as hepatotoxicity and anti-androgenic side effects like gynaecomastia, cheilitis has never been reported with the use of this drug. Hence, it begins imperative to screen for cheilitis, along with other side effects, while using this drug."
Adverse events • Dermatology • Hepatology • Infectious Disease • Pruritus
September 20, 2024
Randomized controlled study on the treatment of mild to moderate atopic dermatitis with licorice extract cream
(ChiCTR)
- P=N/A | N=72 | Recruiting | Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai; Yueyang Hospital of Integrated Traditional Chinese and Western Medi
New trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
September 20, 2024
Efficacy and safety of LED-LLLT for treatment of patients with seborrheic dermatitis: a multicenter, single-blind, randomized, clinical Trial
(ChiCTR)
- P=N/A | N=80 | Not yet recruiting | Sponsor: Xiangya Hospital of Central South University; Xiangya Hospital Central South University
New trial • Dermatitis • Dermatology • Immunology • Seborrheic Dermatitis
1 to 25
Of
62
Go to page
1
2
3